<nav class="container px-0">
  <div class="tarea" *ngFor="let area of tAreas">
    <h3 class="tarea-title">
      {{ area.name }}
    </h3>
    <div class="tarea-group">
      <button
        [class.active]="disease.parameterName === currentDisease.parameterName"
        [routerLink]="['/trial/'] + disease.parameterName"
        class="btn btn-primary btn-trial"
        *ngFor="let disease of area.diseases"
        (click)="loadData(disease.parameterName)"
      >
        {{ disease.primaryName }}<span>{{ disease.secondaryName }}</span>
      </button>
    </div>
  </div>
</nav>
<div class="trial-contain">
  <div class="card flex-row" *ngIf="currentDisease">
    <div class="card-header rounded-left flex-auto bg-secondary">
      <div [ngClass]="{ 'trial-transition': isTransition }">
        Compound ({{ currentCompoundInfo.compoundCount }})
        <h1 [innerHTML]="currentCompoundInfo.primaryName"></h1>
        <h2>{{ currentCompoundInfo.secondaryName }}</h2>
      </div>
    </div>
    <div class="card-body d-flex flex-column align-items-start text-primary">
      <div [ngClass]="{ 'trial-transition': isTransition }">
        <div class="card-body__group">
          <h5 class="card-title">
            Trials ({{ currentDisease.trials.length }})
          </h5>
          <div
            class="sub-trials-links"
            *ngIf="currentDisease.trials.length > 1"
          >
            <button
              class="btn btn-link"
              [class.active]="subParameter === trial.parameterName"
              (click)="loadSubTrialsFromTrialLinks(trial.parameterName)"
              *ngFor="let trial of currentDisease.trials; let i = index"
            >
              {{ trial.name }}
            </button>
          </div>
        </div>
        <div
          class="card-content"
          *ngIf="currentParams === 'uc' || currentParams === 'ln'"
        >
          <div *ngIf="currentParams === 'uc'">
            <!-- sub trial buttons -->
            <div
              [@flipCardFront]="!!cardFlipped"
              class="card-body__indent sub-trials"
            >
              <button
                *ngFor="let trial of currentDisease.trials"
                class="btn btn-secondary btn-disease"
                (click)="loadSubTrials(trial.parameterName)"
              >
                Phase {{ trial.phase }} <span>{{ trial.name }}</span>
              </button>
              <p class="footnotes">
                *This compound is an investigational agent in the therapeutic
                focus area(s) and is not approved. Its safety and efficacy have
                not been established.
              </p>
            </div>
            <!-- sub trial data cards -->
            <div [@flipCardBack]="!!cardFlipped">
              <div class="card-body__indent trials-uc-ln">
                <div *ngIf="subParameter === 'uc1'">
                  <button
                    class="btn btn-link btn-close btn-subtrial-close"
                    (click)="loadSubTrials(currentDisease.parameterName)"
                  >
                    <span class="fa-stack fa-2x">
                      <i class="fas fa-circle fa-stack-2x text-secondary"></i>
                      <i class="fal fa-times fa-stack-1x fa-inverse"></i>
                    </span>
                    Close
                  </button>
                  Phase II
                  <h3>1368-0004</h3>
                  <ul>
                    <li>
                      N = 10
                    </li>
                    <li>
                      Open-label, exploratory study
                    </li>
                    <li>
                      Primary endpoint: Change in gene expression through Week
                      12
                    </li>
                    <li>
                      ClinicalTrials.gov identifier: NCT03100864; EudraCT No.:
                      2017-000100-20
                    </li>
                  </ul>
                  <p class="footnotes">
                    *This compound is an investigational agent in the
                    therapeutic focus area(s) and is not approved. Its safety
                    and efficacy have not been established.<br />
                    ClinicalTrials.gov. Available at:
                    https://www.clinicaltrials.gov/ct2/show/NCT03100864
                    (Accessed 17 January 2019)
                  </p>
                </div>
                <div *ngIf="subParameter === 'uc2'">
                  <button
                    class="btn btn-link btn-close btn-subtrial-close"
                    (click)="loadSubTrials(currentDisease.parameterName)"
                  >
                    <span class="fa-stack fa-2x">
                      <i class="fas fa-circle fa-stack-2x text-secondary"></i>
                      <i class="fal fa-times fa-stack-1x fa-inverse"></i>
                    </span>
                    Close
                  </button>
                  Phase II/III
                  <h3>1368-0005</h3>
                  <ul>
                    <li>
                      N = 550
                    </li>
                    <li>
                      Multicenter, randomized, double-blind, placebo-controlled
                      study
                    </li>
                    <ul>
                      <li>
                        Phase II: Proof-of-concept study of BI 655130* in
                        patients with moderate to severely active ulcerative
                        colitis who have failed previous treatments to identify
                        efficacious and safe dose regimens
                      </li>
                      <li>
                        Phase III: Confirm efficacy and safety of BI 655130* in
                        patients with moderate to severely active ulcerative
                        colitis who have failed previous biologic regimens
                      </li>
                    </ul>
                    <li>
                      Primary endpoint: Proportion of patients with clinical
                      remission at Week 12
                    </li>
                    <li>
                      ClinicalTrials.gov identifier: NCT03482635; EudraCT No.:
                      2017-004230-28
                    </li>
                  </ul>
                  <p class="footnotes">
                    *This compound is an investigational agent in the
                    therapeutic focus area(s) and is not approved. Its safety
                    and efficacy have not been established.<br />
                    ClinicalTrials.gov. Available at:
                    https://www.clinicaltrials.gov/ct2/show/NCT03482635
                    (Accessed 17 January 2019)
                  </p>
                </div>
                <div *ngIf="subParameter === 'uc3'">
                  <button
                    class="btn btn-link btn-close btn-subtrial-close"
                    (click)="loadSubTrials(currentDisease.parameterName)"
                  >
                    <span class="fa-stack fa-2x">
                      <i class="fas fa-circle fa-stack-2x text-secondary"></i>
                      <i class="fal fa-times fa-stack-1x fa-inverse"></i>
                    </span>
                    Close
                  </button>
                  Phase II
                  <h3>1368-0010</h3>
                  <ul>
                    <li>
                      N = 30
                    </li>
                    <li>
                      Multicenter, randomized, double-blind, placebo-controlled,
                      proof-of-concept study
                    </li>
                    <li>
                      Primary endpoint: Proportion of patients with mucosal
                      healing (MCS mESS &le; 1) at Week 8
                    </li>
                    <li>
                      ClinicalTrials.gov identifier: NCT03123120; EudraCT No.:
                      2016-004572-21
                    </li>
                  </ul>
                  <p class="footnotes">
                    *This compound is an investigational agent in the
                    therapeutic focus area(s) and is not approved. Its safety
                    and efficacy have not been established.<br />
                    MCS, Mayo Clinic Score; mESS, modified Endoscopic
                    Subscore.<br />
                    ClinicalTrials.gov. Available at:
                    https://www.clinicaltrials.gov/ct2/show/NCT03123120
                    (Accessed 17 January 2019)
                  </p>
                </div>
              </div>
            </div>
          </div>

          <div *ngIf="currentParams === 'ln'">
            <!-- sub trial buttons -->
            <div
              [@flipCardFront]="!!cardFlipped"
              class="card-body__indent sub-trials"
            >
              <button
                *ngFor="let trial of currentDisease.trials"
                class="btn btn-secondary btn-disease"
                (click)="loadSubTrials(trial.parameterName)"
              >
                Phase {{ trial.phase }} <span>{{ trial.name }}</span>
              </button>
              <p class="footnotes">
                <sup>*</sup>This compound is an investigational agent in the
                therapeutic focus area(s) and is not approved. Its safety and
                efficacy have not been established. <br /><sup>‚úù</sup>BI 655064
                is part of a collaboration with Pharmacy Company; Company Brand is
                currently responsible for the clinical development and Pharmacy Company
                may elect to advance the program after completion of certain
                undisclosed clinical achievements.
              </p>
            </div>
            <!-- sub trial data cards -->
            <div [@flipCardBack]="!!cardFlipped">
              <div class="card-body__indent trials-uc-ln">
                <div *ngIf="subParameter === 'ln1'">
                  <button
                    class="btn btn-link btn-close btn-subtrial-close"
                    (click)="loadSubTrials(currentDisease.parameterName)"
                  >
                    <span class="fa-stack fa-2x">
                      <i class="fas fa-circle fa-stack-2x text-secondary"></i>
                      <i class="fal fa-times fa-stack-1x fa-inverse"></i>
                    </span>
                    Close
                  </button>
                  Phase II
                  <h3>1293-0010</h3>
                  <ul>
                    <li>
                      N = 120
                    </li>
                    <li>
                      Multicenter, randomized, double-blind, placebo-controlled
                      study
                    </li>
                    <li>
                      Patients with active lupus nephritis
                    </li>
                    <li>
                      Primary endpoint: Proportion of patients with CRR at Week
                      52
                    </li>
                    <li>
                      ClinicalTrials.gov identifier: NCT02770170; EudraCT No.:
                      2015-001750-15
                    </li>
                  </ul>
                  <p class="footnotes">
                    <sup>*</sup>This compound is an investigational agent in the
                    therapeutic focus area(s) and is not approved. Its safety
                    and efficacy have not been established.<br />
                    ‚úùBI 655064 is part of a collaboration with Pharmacy Company;
                    Company Brand is currently responsible for the
                    clinical development and Pharmacy Company may elect to advance the
                    program after completion of certain undisclosed clinical
                    achievements.<br />
                    CRR, complete renal response.<br />ClinicalTrials.gov.
                    Available at:
                    https://www.clinicaltrials.gov/ct2/show/NCT02770170
                    (Accessed 17 January 2019)
                  </p>
                </div>
                <div *ngIf="subParameter === 'ln2'">
                  <button
                    class="btn btn-link btn-close btn-subtrial-close"
                    (click)="loadSubTrials(currentDisease.parameterName)"
                  >
                    <span class="fa-stack fa-2x">
                      <i class="fas fa-circle fa-stack-2x text-secondary"></i>
                      <i class="fal fa-times fa-stack-1x fa-inverse"></i>
                    </span>
                    Close
                  </button>
                  Phase II
                  <h3>1293-0013</h3>
                  <ul>
                    <li>
                      N = 150
                    </li>
                    <li>
                      Multicenter, randomized, double-blind, placebo-controlled
                      study
                    </li>
                    <li>
                      Patients with lupus nephritis who have achieved a CRR or a
                      PRR or proteinuria &le; 1 g/day (or urine
                      protein/creatinine ratio &le; 1) in NCT02770170
                    </li>
                    <li>
                      Primary endpoint: Proportion of patients with CRR and
                      without any renal flares at Week 52
                    </li>
                    <li>
                      ClinicalTrials.gov identifier: NCT03385564; EudraCT No.:
                      2017-003101-17
                    </li>
                  </ul>
                  <p class="footnotes">
                    <sup>*</sup>This compound is an investigational agent in the
                    therapeutic focus area(s) and is not approved. Its safety
                    and efficacy have not been established.<br />
                    ‚úùBI 655064 is part of a collaboration with Pharmacy Company;
                    Company Brand is currently responsible for the
                    clinical development and Pharmacy Company may elect to advance the
                    program after completion of certain undisclosed clinical
                    achievements.<br />
                    CRR, complete renal response; PRR, partial renal
                    response.<br />
                    ClinicalTrials.gov. Available at:
                    https://www.clinicaltrials.gov/ct2/show/NCT03385564
                    (Accessed 17 January 2019)
                  </p>
                </div>
              </div>
            </div>
          </div>
        </div>
        <!-- single trial data cards -->
        <div
          class="card-body__indent trials-uc-ln"
          *ngIf="currentParams !== 'uc' && currentParams !== 'ln'"
        >
          Phase {{ currentTrial.phase }}
          <h3>{{ currentTrial.name }}</h3>
          <ul>
            <span *ngFor="let detail of currentTrial.details">
              <li *ngIf="stringCheck(detail)" [innerHTML]="detail"></li>
              <ul *ngIf="!stringCheck(detail)">
                <li
                  *ngFor="let subDetail of detail"
                  [innerHTML]="subDetail"
                ></li>
              </ul>
            </span>
          </ul>
          <p class="footnotes">
            <span *ngFor="let footnote of currentTrial.footnotes">
              <span [innerHTML]="footnote"></span>
              <br />
            </span>
          </p>
        </div>
      </div>
    </div>
  </div>
</div>
<app-home-menu-btn></app-home-menu-btn>
